Kohjin Bio Co (TSE:177A) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:177A Kohjin Bio Co Ltd TSE:177A
18 GF Score
Price 円922.00
! 3 Warning Signs
View Full Analysis

What is Kohjin Bio Co Research & Development?

Kohjin Bio Co TSE:177A -3.66% 18 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:177A with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Kohjin Bio Co's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Kohjin Bio Co  (TSE:177A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kohjin Bio Co Research & Development Related Terms

Kohjin Bio Co Research & Development Historical Data

* Premium members only.

The historical data trend for Kohjin Bio Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co Research & Development Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
0.00 0.00 0.00 0.00 0.00

Kohjin Bio Co Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
TSE:177A
18GF Score
Kohjin Bio Co Ltd TSE:177A
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kohjin Bio Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Kohjin Bio Co (TSE:177A) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Kohjin Bio Co and its competitors.
Is Kohjin Bio Co's Research & Development too high?
Kohjin Bio Co's current Research & Development is 円0 Mil. Overall, Kohjin Bio Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Research & Development compare to VRTX and REGN?
Kohjin Bio Co's Research & Development of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Research & Development of 円0 Mil. The current Research & Development is 円0 Mil. Kohjin Bio Co's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kohjin Bio Co Business Description

Address 5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
18GF Score

Get the complete analysis for TSE:177A

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円922.00
Price